FDA applicant
Agendia BV
FDA records 8 decisions for Agendia BV (Amsterdam, NL) from 2007 to 2022: 7 510(k) clearances and 1 De Novo grant. All are in product code NYI (Classifier, Prognostic, Recurrence Risk…). Its devices cite 7 predicates, 7 of them its own earlier devices. 1 recall is linked to its devices.
FDA’s records also spell it “Agendia”, “Agendia, Inc.”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Agendia BV’s devices, and how often a recall has named them.
FDA decisions per year
1in 2022
2026 so far, outlined.
Recalls per year
1in 2010
Class I Class II/III not classified
Planning a device like Agendia BV’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report